Analyze Diet
Equine veterinary journal2024; 57(4); 1118-1126; doi: 10.1111/evj.14423

In vitro antimicrobial activity of non-traditional therapies for infectious endometritis in mares.

Abstract: Endometritis is the leading cause of subfertility in horses, and it is a clinical problem where historically antibiotics have not always been used with prudent justification. Because of this, alternative therapies to treat endometritis are necessary for the rational use of antibiotics. Objective: To assess the in vitro antimicrobial activity of non-traditional therapies commonly used in clinical practice against microorganisms causing infectious endometritis in mares. Methods: In vitro experiments. Methods: A microdilution technique was performed to determine the minimum inhibitory concentrations (MIC) of 50%, 90% and 100% of microorganisms and the percentage of inhibition (PI) of each therapy against each microorganism (Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Candida sp.). The MIC 50% and 90% were determined using non-linear regression, while MIC 100% was assessed using the resazurin dye technique. The serial PI was evaluated for each therapy using a spectrophotometer. Results: All the therapies demonstrated a PI higher than positive controls for all microorganisms (p < 0.05); however, the only therapies that presented MIC 100 values were hydrogen peroxide and platelet-rich and -poor plasma. Conclusions: In vivo, safety and treatment efficacy were not tested. Conclusions: Hydrogen peroxide and platelet-rich and -poor plasma might be alternatives to traditional therapies for endometritis to support a reduction in antibiotic use.
Publication Date: 2024-10-21 PubMed ID: 39431554PubMed Central: PMC12135747DOI: 10.1111/evj.14423Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the effectiveness of non-traditional therapies against bacteria causing endometritis in horses. The in-vitro tests highlight that hydrogen peroxide and plasma treatments could provide alternatives to antibiotics.

Objective and Methodology

These researchers worked towards evaluating the antimicrobial activity of alternative therapies commonly used in clinical practice against bacteria causing endometritis in horses. Endometritis is an inflammation of the inner layer of the uterus which is a leading cause of subfertility in horses.

  • A microdilution technique was used to ascertain the lowest amount (minimum inhibitory concentrations or MIC) of a therapy required to inhibit the growth of these bacteria by 50%, 90%, and 100%.
  • The bacteria they focused on were Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus, and fungus Candida sp.
  • They also evaluated the percentage of inhibition (PI) of each therapy against each microorganism.
  • Non-linear regression was utilised for determining MIC at 50% and 90% level while the resazurin dye technique helped determine the concentration for 100% inhibition.
  • The serial percentage inhibition for each therapy was checked using a spectrophotometer.

Outcome of the Study

The study brings to light that all tested therapies showed percentage inhibition higher than the positive controls for all studied organisms.

  • However, only hydrogen peroxide and plasma therapies, both rich and poor in platelets, showed 100% inhibition at specific concentrations.

Conclusion

While the study does indicate that hydrogen peroxide and plasma therapies might be alternatives to traditional antibiotic treatments, it also highlights the limitations of the investigation.

  • The antimicrobial effectiveness of these therapies was tested only in vitro and not on live subjects (in vivo).
  • The researchers have not tested for the safety and efficacy of the treatment in practice.
  • Despite these limitations, the study provides essential insights and triggers a need for more extensive in vivo studies in the future.

Cite This Article

APA
Mazzuchini MP, Lisboa FP, de Castro JI, Alvarenga MA, Segabinazzi LGTM, Canisso IF. (2024). In vitro antimicrobial activity of non-traditional therapies for infectious endometritis in mares. Equine Vet J, 57(4), 1118-1126. https://doi.org/10.1111/evj.14423

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 57
Issue: 4
Pages: 1118-1126

Researcher Affiliations

Mazzuchini, Mariana P
  • Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois Urbana-Champaign, Champaign, Illinois, USA.
  • Department of Animal Reproduction and Veterinary Radiology, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil.
Lisboa, Fernando Paixão
  • Department of Animal Reproduction and Veterinary Radiology, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil.
de Castro, Jessica I
  • Institute of Biotechnology, University of Caxias do Sul (UCS), Caxias do Sul, Rio Grande do Sul, Brazil.
Alvarenga, Marco A
  • Department of Animal Reproduction and Veterinary Radiology, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil.
Segabinazzi, Lorenzo G T M
  • Ross University School of Veterinary Medicine, Basseterre, St. Kitts, West Indies.
Canisso, Igor F
  • Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois Urbana-Champaign, Champaign, Illinois, USA.

MeSH Terms

  • Animals
  • Female
  • Endometritis / veterinary
  • Endometritis / microbiology
  • Endometritis / therapy
  • Endometritis / drug therapy
  • Horses
  • Horse Diseases / microbiology
  • Horse Diseases / therapy
  • Horse Diseases / drug therapy
  • Microbial Sensitivity Tests / veterinary
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Bacterial Agents / pharmacology
  • Bacteria / drug effects
  • Candida / drug effects
  • Bacterial Infections / veterinary
  • Bacterial Infections / drug therapy
  • Bacterial Infections / microbiology
  • Anti-Infective Agents / therapeutic use
  • Anti-Infective Agents / pharmacology
  • Hydrogen Peroxide / therapeutic use
  • Hydrogen Peroxide / pharmacology

Grant Funding

  • 2021/05152-0 / São Paulo Research Foundation (FAPESP)

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 57 references
  1. Nielsen HJ. Endometritis in the mare: a diagnostic study comparing cultures from swab and biopsy.. Theriogenology 2005;106:510–518.
    pubmed: 15978661
  2. Rasmussen CD, Petersen MR, Bojesen AM, Pedersen HG, Lehn‐Jensen H, Christoffersen M. Equine infectious endometritis‐clinical and subclinical cases.. J Equine Vet Sci 2015;35:95–104.
  3. Riddle WT, LeBlanc MM, Stromberg AJ. Relationships between uterine culture, cytology, and pregnancy rates in a thoroughbred practice.. Theriogenology 2007;68:395–402.
    pubmed: 17583785
  4. Canisso IF, Segabinazzi LGTM, Fedorka CE. Persistent breeding‐induced endometritis in mares—a multifaceted challenge: from clinical aspects to immunopathogenesis and pathobiology.. Int J Mol Sci 2020;21(4):1432.
    pmc: PMC7073041pubmed: 32093296
  5. Ferris RA. Therapeutics for infectious endometritis: a clinical perspective.. Rev Bras Reprod Anim 2017;41:175–179.
  6. Malaluang P, Wilén E, Lindahl J, Hansson I, Morrell JM. Antimicrobial resistance in equine reproduction.. Animals 2021;11(11):3035.
    pmc: PMC8614435pubmed: 34827768
  7. Troedsson MHT, Nielsen JM. Non‐antibiotic treatment of equine endometritis.. Pferdeheilkunde 2018;34:17–22.
  8. Buczkowska J, Kozdrowski R, Sikora M, Dzięcioł M, Matusz A. Non‐traditional treatments for endometritis in mares.. Bulg J Vet Med 2015;18:285–293.
  9. Rex JH, Fernandez Lynch H, Cohen IG, Darrow JJ, Outterson K. Designing development programs for non‐traditional antibacterial agents.. Nat Commun 2019;10:3416.
    pmc: PMC6668399pubmed: 31366924
  10. Ferris RA, McCue PM, Borlee GI, Loncar KD, Hennet ML, Borlee BR. In vitro efficacy of nonantibiotic treatments on biofilm disruption of Gram‐negative pathogens and an in vivo model of infectious endometritis utilizing isolates from the equine uterus.. J Clin Microbiol 2016;54:631–639.
    pmc: PMC4768000pubmed: 26719448
  11. Scoggin CF. Endometritis: non‐traditional therapies.. Vet Clin N Am Equine Pract 2016;32:499–511.
    pubmed: 27726985
  12. McCue PM, Ferris RA. Formulary and protocols in equine reproduction.. Fort Collins, CO: Colorado State University College of Veterinary Medicine and Biomedical Sciences; 2016.
  13. Smith OJ, Wicaksana A, Davidson D, Spratt D, Mosahebi A. An evaluation of the bacteriostatic effect of platelet‐rich plasma.. Int Wound J 2021;18:448–456.
    pmc: PMC8273594pubmed: 33476481
  14. Cieślik‐Bielecka A, Bold T, Ziółkowski G, Pierchała M, Królikowska A, Reichert P. Antibacterial activity of leukocyte‐ and platelet‐rich plasma: an in vitro study.. Biomed Res Int 2018;2018:9471723.
    pmc: PMC6040244pubmed: 30050949
  15. Drago L, Bortolin M, Vassena C, Taschieri S, del Fabbro M. Antimicrobial activity of pure platelet‐rich plasma against microorganisms isolated from oral cavity.. BMC Microbiol 2013;13:47.
    pmc: PMC3599521pubmed: 23442413
  16. Marini MG, Perrini C, Esposti P, Corradetti B, Bizzaro D, Riccaboni P. Effects of platelet‐rich plasma in a model of bovine endometrial inflammation in vitro.. Reprod Biol Endocrinol 2016;14(1):58.
    pmc: PMC5020481pubmed: 27619959
  17. Jasmine S, Thangavelu A, Janarthanan K, Krishnamoorthy R, Alshatwi AA. Antimicrobial and antibiofilm potential of injectable platelet rich fibrin—a second‐generation platelet concentrate—against biofilm producing oral Staphylococcus isolates.. Saudi J Biol Sci 2020;27:41–46.
    pmc: PMC6933211pubmed: 31889815
  18. Segabinazzi LGTM, Canisso IF, Podico G, Cunha LL, Novello G, Rosser MF. Intrauterine blood plasma platelet‐therapy mitigates persistent breeding‐induced endometritis, reduces uterine infections, and improves embryo recovery in mares.. Antibiotics 2021;10(5):490.
    pmc: PMC8146422pubmed: 33922743
  19. Pham TAV, Tran TTP, Luong NTM. Antimicrobial effect of platelet‐rich plasma against Porphyromonas gingivalis .. Int J Dent 2019;2019:7329103.
    pmc: PMC6535835pubmed: 31214262
  20. El‐Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M. Platelet‐rich plasma: growth factors and pro‐ and anti‐inflammatory properties.. J Periodontol 2007;78:661–669.
    pubmed: 17397313
  21. Ravaioli V, Raffini E, Tamburini M, Galletti G, Frasnelli M. Infectious endometritis in mares: microbiological findings in field samples.. J Equine Vet Sci 2022;112:103913.
    pubmed: 35196546
  22. Bizzini A, Durussel C, Bille J, Greub G, Prodhom G. Performance of matrix‐assisted laser desorption ionization‐time of flight mass spectrometry for identification of bacterial strains routinely isolated in a clinical microbiology laboratory.. J Clin Microbiol 2010;48:1549–1554.
    pmc: PMC2863943pubmed: 20220166
  23. Frank JA, Reich CI, Sharma S, Weisbaum JS, Wilson BA, Olsen GJ. Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes.. Appl Environ Microbiol 2008;74:2461–2470.
    pmc: PMC2293150pubmed: 18296538
  24. Morris LH, McCue PM, Aurich C. Equine endometritis: a review of challenges and new approaches.. Reproduction 2020;160:95–110.
    pubmed: 32805710
  25. Pottz GE, Rampey JH, Benjamin F. The effect of dimethyl sulfoxide (DMSO) on antibiotic sensitivity of a group of medically important microorganisms: preliminary report.. Ann N Y Acad Sci 1967;141(1):261–272.
    pubmed: 4382715
  26. Ley WB, Bowen JM, Sponenberg DPP, Lessardl PN. Dimethyl sulfoxide intrauterine therapy in the mare: effects upon endometrial histological features and biopsy classification.. Theriogenology 1989;32:263–276.
    pubmed: 16726673
  27. Olsen LM, Al‐Bagdadi FK, Richardson GF, Archbald LF, Braun WF, McCoy DJ. A histological study of the effect of saline and povidone‐iodine infusions on the equine endometrium.. Theriogenology 1992;37(6):1311–1325.
  28. Köhne M, Hofbauer L, Bottcher D, Tonissen A, Hegger A, Gorgens A. Comparison of systemic trimethoprim‐sulfadimethoxine treatment and intrauterine ozone application as possible therapies for bacterial endometritis in equine practice.. Front Vet Sci 2023;10:1102149.
    pmc: PMC9911668pubmed: 36777673
  29. NCCLS. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard.. Wayne, PA: Clinical and Laboratory Standards Institute; 2019.
  30. Lisboa FP, Silvestre WP, Castro JO, Martins GV, Segabinazzi LGTM, Pauletti GF. In vitro antimicrobial activity of selected essential oils against endometritis‐causing microorganisms in mares.. J Equine Vet Sci 2022;110:103840.
    pubmed: 34923074
  31. Green KJ, Dods K, Hammer KA. Development and validation of a new microplate assay that utilises optical density to quantify the antibacterial activity of honeys including Jarrah, Marri and Manuka.. PLoS One 2020;15(12):e0243246.
    pmc: PMC7725308pubmed: 33296391
  32. Segabinazzi LGTM, Podico G, Rosser MF, Nanjappa SG, Alvarenga MA, Canisso IF. Three manual noncommercial methods to prepare equine platelet‐rich plasma.. Animals 2021;11(6):1478.
    pmc: PMC8223772pubmed: 34063777
  33. Bielecki TM, Gazdzik TS, Arendt J, Szczepanski T, Król W, Wielkoszynski T. Antibacterial effect of autologous platelet gel enriched with growth factors and other active substances an in vitro study.. J Bone Joint Surg Br 2007;89(3):417–420.
    pubmed: 17356164
  34. Hays JP, Ruiz‐Alvarez MJ, Roson‐Calero N, Amin R, Murugaiyan J, Van Dongen MBM. Perspectives on the ethics of antibiotic overuse and on the implementation of (new) antibiotics.. Infect Dis Ther 2022;11:1315–1326.
    pmc: PMC9127288pubmed: 35608734
  35. Strejcek M, Smrhova T, Junkova P, Uhlik O. Whole‐cell MALDI‐TOF MS versus 16S rRNA gene analysis for identification and dereplication of recurrent bacterial isolates.. Front Microbiol 2018;9:1294.
    pmc: PMC6018384pubmed: 29971049
  36. Timperio AM, Gorrasi S, Zolla L, Fenice M. Evaluation of MALDI‐TOF mass spectrometry and MALDI BioTyper in comparison to 16S rDNA sequencing for the identification of bacteria isolated from Arctic Sea water.. PLoS One 2017;12(7):e0181860.
    pmc: PMC5524297pubmed: 28738078
  37. Katila T, Ferreira‐Dias G. Evolution of the concepts of endometrosis, post breeding endometritis, and susceptibility of mares.. Animals 2022;12(6):779.
    pmc: PMC8944725pubmed: 35327176
  38. Loncar KD, Ferris RA, McCue PM, Borlee GI, Hennet ML, Borlee BR. In vitro biofilm disruption and bacterial killing using nonantibiotic compounds against Gram‐negative equine uterine pathogens.. J Equine Vet Sci 2017;53:94–99.
  39. Lorian V. Differences between in vitro and in vivo studies: letter to the editor.. Antimicrob Agents Chemother 1988;32:1600–1601.
    pmc: PMC175930pubmed: 3190189
  40. Yarza P, Yilmaz P, Pruesse E, Glöckner FO, Ludwig W, Schleifer KH. Uniting the classification of cultured and uncultured bacteria and archaea using 16S rRNA gene sequences.. Nat Rev Microbiol 2014;12:635–645.
    pubmed: 25118885
  41. Mah T‐FC, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents.. Trends Microbiol 2001;9(1):34–39.
    pubmed: 11166241
  42. Berlanga M, Guerrero R. Living together in biofilms: the microbial cell factory and its biotechnological implications.. Microb Cell Fact 2016;15:165.
    pmc: PMC5045575pubmed: 27716327
  43. Wood DCC, Wood J. Pharmacologic and biochemical considerations of dimethyl sulfoxide.. Ann N Y Acad Sci 1975;243:7–19.
    pubmed: 1093465
  44. Tunçer S, Gurbanov R, Sheraj I, Solel E, Esenturk O, Banerjee S. Low dose dimethyl sulfoxide driven gross molecular changes have the potential to interfere with various cellular processes.. Sci Rep 2018;8:14828.
    pmc: PMC6172209pubmed: 30287873
  45. Rosol T, Threlfall WR. Histopathologic effects of dimethyl sulfoxide on equine endometrium.. Am J Vet Res 1988;49:1775–1781.
    pubmed: 3189996
  46. Barreto R, Barrois B, Lambert J, Malhotra‐Kumar S, Santos‐Fernandes V, Monstrey S. Addressing the challenges in antisepsis: focus on povidone iodine.. Int J Antimicrob Agents 2020;56(3):106064.
    pubmed: 32599228
  47. Tsuda S, Soutome S, Hayashida S, Funahara M, Yanamoto S, Umeda M. Topical povidone iodine inhibits bacterial growth in the oral cavity of patients on mechanical ventilation: a randomized controlled study.. BMC Oral Health 2020;20(1):62.
    pmc: PMC7041202pubmed: 32093667
  48. Lowe DO, Knowles SR, Weber EA, Railton CJ, Shear NH. Povidone‐iodine‐induced burn: case report and review of the literature.. Pharmacotherapy 2006;26:1641–1645.
    pubmed: 17064209
  49. Mahal JS, Honparkhe M, Kumar A, Singh P. Efficacy of intrauterine hydrogen peroxide and povidone iodine administration to treat endometritic mares.. Int J Curr Microbiol Appl Sci 2020;9:2427–2431.
  50. Ávila ACA, Diniz NC, Serpa RT, Chaves MMB de C, Viu MA de O, de Oliveira RA. Effectiveness of ozone therapy in the treatment of endometritis in mares.. J Equine Vet Sci 2022;112:103900.
    pubmed: 35183680
  51. Silva FFA, do Nascimento EM, de Paula LAO, Sandri D, Pagliosa GM, ECB do P G. Use of ozone therapy to control chronic pain in equine laminitis.. J Ozone Ther 2021;5(6):20–26.
  52. Mazzuchini MP, Garrido L, Segabinazzi TM, Tongu EA, Tiemi C, Okada C. Safety of uterine lavage with ozonated saline in mares.. Arch Vet Sci 2022;27:88–104.
  53. Elvis AM, Ekta JS. Ozone therapy: a clinical review.. J Nat Sci Biol Med 2011;2:66–70.
    pmc: PMC3312702pubmed: 22470237
  54. Li H, Li B. PRP as a new approach to prevent infection: preparation and in vitro antimicrobial properties of PRP.. J Vis Exp 2013;74:50351.
    pmc: PMC3653398pubmed: 23609458
  55. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet‐rich plasma: implications for wound healing.. Plast Reconstr Surg 2004;114:1502–1508.
    pubmed: 15509939
  56. Palankar R, Kohler TP, Krauel K, Wesche J, Hammerschmidt S, Greinacher A. Platelets kill bacteria by bridging innate and adaptive immunity via platelet factor 4 and FcγRIIA.. J Thromb Haemost 2018;16:1187–1197.
    pubmed: 29350833
  57. Cieslik‐Bielecka A, Gazdzik TS, Bielecki TM, Cieslik T. Why the platelet‐rich gel has antimicrobial activity?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103:303–305.
    pubmed: 17197209